Promethera Biosciences
Innovative biopharmaceuticals harnessing healthy human liver cells to treat liver diseases with groundbreaking stem cell technology.
General Information
BounceWatch is an independent company data service, not affiliated with Promethera Biosciences. To contact Promethera Biosciences, visit promethera.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Promethera Biosciences compare?
A PDF of Promethera Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Promethera Biosciences soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Promethera Biosciences on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About Promethera Biosciences
Business keywords: Biopharmaceuticals, Cell therapy, Liver diseases, Stem cell technology, Regenerative medicine, Chronic liver disease, NASH, ACLF, Fatty liver, Clinical stage, Liver-based genetic diseases, Innovative treatments, Acquired liver diseases, Antibodies
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series D | €7.50M | 2 |
|
16 Dec 2019 |
| Series D | $48.06M | 2 |
|
30 Jun 2019 |
| Convertible Note | €9.30M | 2 |
|
10 Apr 2018 |
| Series C | €10.00M | 7 |
|
27 Oct 2016 |
| Series C | €25.30M | 3 |
|
25 Nov 2014 |
| Series B | €23.60M | 3 |
|
28 Mar 2012 |
| Series A | $7.30M | 4 |
|
02 Feb 2010 |
Promethera Biosciences Alternatives & Competitors
View All Alternatives
Off-the-shelf cell therapies for liver disease
REVOLUTIONIZING CARE FOR CHRONIC BACK PAIN
Developing first-in-class therapies designed to defeat chronic inflammation and fibrosis at the sour...
FAQ About Promethera Biosciences
Source: BounceWatch company record for Promethera Biosciences, https://bouncewatch.com/company/promethera-biosciences, updated 10 October 2024. When citing, please name BounceWatch and link this page.
